EZH2 and cancer: Acetylation at Lys348 (K348) and O-GlcNAcylation at Ser73 (S73) increased the protein stability and catalytic activity of EZH2, further enhancing its ability to promote cancer cell migration and invasion (Figure 5B) [252,253].